GenesisCare UK

GenesisCare UK

Private

Last Round

Debt

12/17/2024

Total Funding Raised

$433M

Company Overview

GenesisCare UK is the UK's leading independent provider of specialist cancer care, operating 14 state-of-the-art outpatient centres. The company provides a range of services including advanced diagnostics, medical oncology, radiotherapy, and Theranostics. It is the UK arm of the global GenesisCare group, which was originally founded in Australia. In June 2023, the parent company filed for Chapter 11 bankruptcy in the US, emerging in February 2024 after a restructuring. This reorganisation established GenesisCare UK as an independent business with its own board and strategy, alongside its counterparts in Australia and Spain. Following the restructuring, the UK business secured a £140 million refinancing deal to support its operations and growth, including plans for a new comprehensive cancer centre in Leeds set to open in 2026. The company focuses on an integrated approach to cancer care, treating the whole patient through personalised treatment programs that include wellbeing services and exercise medicine.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenesisCare UK Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenesisCare UK Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Debt12/17/2024
Corporate Funding2/16/2024
Debt6/1/2023
Secondary10/26/2018
Buyout/LBO7/26/2016
Buyout/LBO
8/31/2012

GenesisCare UK Investors

Notable investors and investment history

InvestorRounds
China ResourcesBuyout/LBO
Avenue Capital GroupDebt
KKRSecondary, Buyout/LBO
Canyon PartnersDebt, Corporate Funding
Bain Capital, LPDebt, Corporate Funding
Pemberton Asset ManagementDebt
Macquarie CapitalBuyout/LBO

GenesisCare UK Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenesisCare UK Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenesisCare UK's valuation, stock price, and market status.

Firmographic Details

HeadquartersHampshire
Year Founded2006
Last Funding12/17/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.